Astrana Health, Inc. (ASTH)
(Real Time Quote from BATS)
$49.50 USD
+0.17 (0.35%)
Updated Jul 22, 2024 02:58 PM ET
4-Sell of 5 4
C Value F Growth A Momentum C VGM
Balance Sheet
Fiscal Year End for Astrana Health, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 296 | 294 | 287 | 261 | 220 |
Receivables | 148 | 124 | 90 | 61 | 76 |
Notes Receivable | 0 | 3 | 4 | 0 | 23 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 17 | 15 | 19 | 17 | 10 |
Total Current Assets | 462 | 435 | 399 | 339 | 329 |
Net Property & Equipment | 7 | 109 | 53 | 30 | 12 |
Investments & Advances | 32 | 41 | 43 | 80 | 29 |
Other Non-Current Assets | 26 | 0 | 1 | 5 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 350 | 353 | 336 | 326 | 342 |
Deposits & Other Assets | 18 | 6 | 6 | 19 | 2 |
Total Assets | 933 | 964 | 852 | 817 | 729 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 60 | 50 | 44 | 36 | 27 |
Current Portion Long-Term Debt | 20 | 1 | 1 | 11 | 10 |
Current Portion Capital Leases | 1 | 1 | 0 | 0 | 0 |
Accrued Expenses | 107 | 84 | 56 | 50 | 59 |
Income Taxes Payable | 0 | 0 | 1 | 4 | 5 |
Other Current Liabilities | 27 | 9 | 11 | 10 | 2 |
Total Current Liabilities | 219 | 147 | 115 | 115 | 105 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 4 | 3 | 9 | 11 | 18 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 259 | 203 | 183 | 230 | 232 |
Non-Current Capital Leases | 1 | 1 | 1 | 0 | 0 |
Other Non-Current Liabilities | 4 | 20 | 15 | 0 | 0 |
Minority Interest (Liabilities) | -206 | 14 | 56 | 114 | 169 |
Total Liabilities | 317 | 409 | 392 | 487 | 536 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 371 | 360 | 311 | 261 | 160 |
Retained Earnings | 243 | 193 | 144 | 70 | 32 |
Other Equity | 2 | 2 | 6 | 0 | 1 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 617 | 555 | 460 | 331 | 192 |
Total Liabilities & Shareholder's Equity | 933 | 964 | 852 | 817 | 729 |
Total Common Equity | 617 | 555 | 460 | 331 | 192 |
Shares Outstanding | 58.20 | 56.70 | 55.50 | 54.20 | 34.80 |
Book Value Per Share | 10.60 | 9.79 | 8.30 | 6.11 | 5.53 |
Fiscal Year End for Astrana Health, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 337 | 296 | 277 | 298 |
Receivables | NA | 184 | 148 | 184 | 151 |
Notes Receivable | NA | 0 | 0 | 1 | 1 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 17 | 17 | 14 | 15 |
Total Current Assets | NA | 539 | 462 | 476 | 465 |
Net Property & Equipment | NA | 8 | 7 | 129 | 124 |
Investments & Advances | NA | 42 | 32 | 47 | 49 |
Other Non-Current Assets | NA | 47 | 26 | 25 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 530 | 350 | 350 | 348 |
Deposits & Other Assets | NA | 21 | 18 | 25 | 23 |
Total Assets | NA | 1,226 | 933 | 1,073 | 1,027 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 146 | 60 | 53 | 50 |
Current Portion Long-Term Debt | NA | 21 | 20 | 3 | 3 |
Current Portion Capital Leases | NA | 1 | 1 | 1 | 1 |
Accrued Expenses | NA | 136 | 107 | 98 | 100 |
Income Taxes Payable | NA | 6 | 0 | 30 | 20 |
Other Current Liabilities | NA | 40 | 27 | 15 | 9 |
Total Current Liabilities | NA | 355 | 219 | 203 | 186 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 4 | 4 | 12 | 12 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 368 | 259 | 206 | 205 |
Non-Current Capital Leases | NA | 1 | 1 | 1 | 1 |
Other Non-Current Liabilities | NA | 4 | 14 | 21 | |
Minority Interest (Liabilities) | NA | -206 | -206 | 18 | 14 |
Total Liabilities | NA | 568 | 317 | 476 | 457 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 395 | 371 | 363 | 357 |
Retained Earnings | NA | 258 | 243 | 231 | 209 |
Other Equity | NA | 4 | 2 | 4 | 4 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 658 | 617 | 598 | 570 |
Total Liabilities & Shareholder's Equity | NA | 1,226 | 933 | 1,073 | 1,027 |
Total Common Equity | 0 | 658 | 617 | 598 | 570 |
Shares Outstanding | 56.00 | 56.00 | 58.20 | 57.50 | 57.50 |
Book Value Per Share | 0.00 | 11.75 | 10.60 | 10.39 | 9.91 |